International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA ; volume:18 ; number:1 ; day:9 ; month:8 ; year:2018 ; pages:1-11 ; date:12.2018
BMC cancer ; 18, Heft 1 (9.8.2018), 1-11, 12.2018

Urheber
Keppens, Cleo
Dequeker, Elisabeth M. C.
Patton, Simon J.
Normanno, Nicola
Fenizia, Francesca
Butler, Rachel
Cheetham, Melanie
Fairley, Jennifer A.
Williams, Hannah
Hall, Jacqueline A.
Schuuring, Ed
Deans, Zandra C.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12885-018-4694-x
URN
urn:nbn:de:101:1-2019112718230781762897
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Keppens, Cleo
  • Dequeker, Elisabeth M. C.
  • Patton, Simon J.
  • Normanno, Nicola
  • Fenizia, Francesca
  • Butler, Rachel
  • Cheetham, Melanie
  • Fairley, Jennifer A.
  • Williams, Hannah
  • Hall, Jacqueline A.
  • Schuuring, Ed
  • Deans, Zandra C.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Biomarkers in cancer/Circulating tumour markers

Biomarkers in cancer/Circulating tumour markers

Circulating Tumour DNA in Melanoma—Clinic Ready?

Circulating Tumour DNA in Melanoma—Clinic Ready?

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?

Ex vivo expansion of circulating tumour cells (CTCs)

Ex vivo expansion of circulating tumour cells (CTCs)

Unravelling mutational signatures with plasma circulating tumour DNA

Unravelling mutational signatures with plasma circulating tumour DNA

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer

Enhanced BARM - Authentic Reporting to External Platforms

Enhanced BARM - Authentic Reporting to External Platforms

Cancer metastasis chemoprevention prevents circulating tumour cells from germination

Cancer metastasis chemoprevention prevents circulating tumour cells from germination

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey

Two magnetic enrichment methods for pancreatic circulating tumour cells detection

Two magnetic enrichment methods for pancreatic circulating tumour cells detection

Verbundene Objekte